Can-Fite BioPharma Ltd.
CANF | AMEX
$2.22
-$0.02 (-0.89%)
At close: Sep 21, 2026, 4:00 PM ET
$2.26
+$0.04 (+1.74%)
Pre-market:
Sep 22, 2026, 6:16 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.33 | -30.01 | -24.56 | -32.61 | -31.33 | -28.06 |
PEG Ratio | 0 | 0.75 | 0.47 | 0.56 | 1.08 | 0.39 |
PS Ratio | 8.07 | 350.86 | 252.38 | 409.58 | 462.64 | 531.13 |
PB Ratio | 0.59 | 43.50 | 30.04 | 74.19 | 27.44 | 66.72 |
P/FCF Ratio | -0.37 | -30.94 | -22.21 | -30.69 | -39.99 | -33.52 |
P/OCF Ratio | -0.37 | -30.97 | -22.22 | -30.72 | -40.03 | -33.59 |
OCF/S Ratio | -2.21K | -1.13K | -1.14K | -1.33K | -1.16K | -1.58K |
Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 3.46 | 4.38 | 4.90 | 3.68 | 7.37 | 7.41 |
Current Ratio | 3.46 | 4.38 | 4.90 | 3.66 | 7.35 | 7.41 |
Asset Turnover | 0.04 | 0.07 | 0.07 | 0.09 | 0.04 | 0.08 |
Interest Coverage | -710.72 | -580.71 | -585.36 | -131.12 | -713.44 | -38.95 |
Return on Equity | -177.15% | -144.96% | -122.28% | -227.48% | -87.57% | -237.78% |
Return on Assets | -104.12% | -86.40% | -76.42% | -109.59% | -62.19% | -151.66% |
Return on Invested Capital | -146.65% | -114.17% | -102.49% | -147.84% | -72.95% | -170.41% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 94.07% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -2.43K% | -1.17K% | -1.03K% | -1.26K% | -1.48K% | -1.89K% |
Pretax Profit Margin | -2.43K% | -1.17K% | -1.03K% | -1.26K% | -1.48K% | -1.89K% |
Operating Profit Margin | -2.46K% | -1.21K% | -1.1K% | -1.25K% | -1.51K% | -1.85K% |
FCF Margin | -2.21K% | -1.13K% | -1.14K% | -1.33K% | -1.16K% | -1.58K% |
EBITDA Margin | -2.45K% | -1.21K% | -1.1K% | -1.24K% | -1.5K% | -1.85K% |
Add to Watchlist
Select watchlists to add or remove CANF